StonvexLoading…
StonvexStonvexStonvexCore line items from AQMS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 | Annual 2021 2021-12-31 |
|---|---|---|---|---|
Revenue | $0.00 | $25.00K | $4.00K | $173.00K |
Operating Income | $-23.85M | $-24.46M | $-15.57M | $-17.46M |
Net Income | $-24.55M | $-23.94M | $-15.43M | $-18.19M |
EPS (Diluted) | $-38.25 | $-5.10 | $-0.20 | $-0.26 |
Total Assets | $26.36M | $33.60M | $33.50M | $33.27M |
Total Liabilities | $10.12M | $7.54M | $12.59M | $5.74M |
Cash & Equivalents | $4.08M | $16.52M | $7.08M | $8.14M |
Free Cash Flow OCF − CapEx | $-21.55M | $-8.79M | $-14.92M | $-9.41M |
Shares Outstanding | 773.08K | 5.39M | 79.48M | 70.42M |